Flexion Therapeutics Announces Pricing of Public Offering of Common Stock
The shares of common stock described above are being offered pursuant to a shelf registration statement previously filed with and declared effective by the
This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
This press release contains forward-looking statements that are based on our current expectations and beliefs. Statements in this press release regarding matters that are not historical facts, including, but not limited to, statements relating to expectations regarding the completion and timing of the public offering, are forward-looking statements. These forward-looking statements are based on management's expectations and assumptions as of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, risks associated with market conditions and the satisfaction of customary closing conditions related to the offering, as well as other risks and uncertainties described in our filings with the
Source: Flexion Therapeutics, Inc.